Cinemark Holdings Inc.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Cinemark Holdings Inc. reported revenue of $3.1B (+2.1% year on year) and net income of $290.0M (-7.3% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Total revenue | $3.1B | $3.0B | $3.1B | $2.5B |
| Film rentals and advertising | $1.8B | $1.7B | $1.7B | $1.4B |
| Concession supplies | $481.0M | $450.8M | $442.6M | $338.6M |
| Salaries and wages | $822.2M | $803.6M | $806.2M | $745.4M |
| Facility lease expense | $643.6M | $650.6M | $659.4M | $616.6M |
| Utilities and other | $969.6M | $918.8M | $933.6M | $814.4M |
| General and administrative | $468.6M | $432.5M | $394.3M | $352.2M |
| Depreciation and amortization | $201.9M | $197.5M | $209.5M | $238.2M |
| Impairment of long-lived and other assets | $6.5M | $1.5M | $16.6M | $174.1M |
| (Gain) loss on disposal of assets and other | $4.2M | $3.2M | ($15.4M) | $0 |
| Total cost of operations | $5.6B | $5.4B | $5.4B | $5.1B |
| Operating income | $670.0M | $722.3M | $729.1M | ($176.6M) |
| Interest expense | ($142.3M) | ($144.0M) | $150.4M | ($155.3M) |
| Interest income | $74.8M | $94.1M | $98.2M | $36.9M |
| Loss on debt amendments and extinguishments | ($1.5M) | $6.9M | $10.7M | — |
| Loss on warrants | ($39.3M) | — | — | — |
| Foreign currency exchange and other related loss | ($19.6M) | ($19.4M) | ($57.6M) | ($23.0M) |
| Interest expense - NCM | ($21.3M) | ($22.0M) | ($22.6M) | ($23.2M) |
| Equity in income | $13.2M | $23.8M | $7.2M | ($18.6M) |
| Net gain (loss) on investment in NCMI | ($24.2M) | $22.0M | — | — |
| Total other expense | ($306.9M) | ($201.2M) | ($270.7M) | ($330.2M) |
| Income before income taxes | $153.9M | $252.8M | $221.4M | ($265.0M) |
| Income taxes | $12.4M | ($60.1M) | $29.9M | $3.0M |
| Net income | $290.0M | $312.9M | $191.5M | ($268.0M) |
| Less: Net income attributable to noncontrolling interests | $6.6M | $6.4M | $3.3M | $6.4M |
| Net income attributable to Cinemark USA, Inc. | $138.2M | $309.7M | $188.2M | ($271.2M) |
| Basic | 115.6M | 119.9M | 119.1M | 118.2M |
| Diluted | 134.3M | 154.9M | 152.0M | 118.2M |
| Basic | $1.18 | $2.54 | $1.55 | -$2.26 |
| Diluted | $1.04 | $2.06 | $1.34 | -$2.26 |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Total revenue | $1.1B | $643.1M | $857.5M | $940.5M |
| Film rentals and advertising | $623.8M | $339.4M | $491.0M | $541.6M |
| Concession supplies | $164.0M | $97.0M | $131.2M | $146.2M |
| Salaries and wages | $233.2M | $188.8M | $212.6M | $218.8M |
| Facility lease expense | $178.0M | $161.8M | $163.8M | $165.8M |
| Utilities and other | $273.4M | $229.4M | $254.8M | $249.4M |
| General and administrative expenses | $124.6M | $111.1M | $123.0M | $107.4M |
| Depreciation and amortization | $51.6M | $51.6M | $50.9M | $49.4M |
| Impairment of long-lived and other assets | $0 | — | $600.0K | $1.6M |
| Loss (gain) on disposal of assets and other | $5.6M | $7.4M | $6.0M | $2.0M |
| Total cost of operations | $1.7B | $1.2B | $1.5B | $1.5B |
| Operating income (loss) | $467.0M | $48.1M | $229.6M | $347.8M |
| Interest expense | ($31.3M) | ($34.7M) | ($32.2M) | ($39.4M) |
| Loss on debt amendments and extinguishments | $2.8M | — | $0 | $1.5M |
| Other income, net | $8.6M | $2.8M | — | — |
| Total other expense | ($59.6M) | ($66.6M) | ($116.4M) | ($66.6M) |
| Loss before income taxes | $407.4M | ($18.5M) | $113.2M | $281.2M |
| Income tax expense | $124.9M | ($7.6M) | $900.0K | $86.1M |
| Net income | $282.5M | ($10.9M) | $112.3M | $195.1M |
| Less: Net income attributable to noncontrolling interests | $2.8M | $1.2M | $2.0M | $2.4M |
| Net income attributable to Cinemark Holdings, Inc. | $139.4M | ($6.4M) | $49.5M | $93.5M |
| Basic | 115.2M | 114.7M | 113.8M | 113.5M |
| Diluted | 116.4M | 114.7M | 123.8M | 149.1M |
| Basic | $1.20 | -$0.06 | $0.43 | $0.81 |
| Diluted | $1.19 | -$0.06 | $0.40 | $0.63 |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $688.4M | $1.9B | $1.5B | $1.1B |
| Inventories | $58.2M | $62.0M | $46.6M | $47.4M |
| Accounts receivable | $220.0M | $208.5M | $158.6M | $138.6M |
| Current income tax receivable | $129.9M | $109.0M | $112.8M | $92.9M |
| Prepaid expenses and other | $94.7M | $97.5M | $101.0M | $101.4M |
| Accounts receivable from parent | $92.8M | $65.5M | $58.6M | $53.4M |
| Total current assets | $1.3B | $2.4B | $1.9B | $1.5B |
| Theatre properties and equipment, net | $1.2B | $1.1B | $1.2B | $1.2B |
| Operating lease right-of-use assets, net | $949.9M | $930.4M | $986.4M | $1.1B |
| Goodwill | $1.2B | $1.2B | $1.3B | $1.3B |
| Intangible assets, net | $300.4M | $300.5M | $302.8M | $304.6M |
| Investment in NCMI | ($301.5M) | ($299.9M) | ($316.9M) | ($323.8M) |
| Investments in affiliates | $47.8M | $52.4M | $47.2M | $45.2M |
| Long-term deferred tax asset | $143.1M | $137.2M | — | — |
| Deferred charges and other assets, net | $53.2M | $56.8M | $66.4M | $72.0M |
| Total other long-term assets | $3.4B | $3.4B | $3.3B | $3.2B |
| Total assets | $8.9B | $10.0B | $9.5B | $9.4B |
| Current portion of long-term debt | $12.8M | $470.7M | $15.6M | $21.4M |
| Current portion of operating lease obligations | $215.0M | $212.1M | $212.5M | $219.3M |
| Current portion of finance lease obligations | $16.5M | $15.4M | $14.0M | $14.4M |
| Current income tax payable | $9.2M | $8.0M | $8.4M | $6.4M |
| Accounts payable | $172.0M | $172.2M | $106.6M | $144.4M |
| Accrued interest | $60.8M | $77.8M | $64.2M | $70.3M |
| Accrued film rentals | $181.4M | $165.8M | $147.6M | $130.2M |
| Accrued payroll | $131.6M | $146.8M | $120.2M | $109.0M |
| Accrued property taxes | $59.2M | $58.0M | $58.8M | $59.2M |
| Accrued other current liabilities (see Note 11) | $301.7M | $270.0M | $239.2M | $200.4M |
| Total current liabilities | $1.7B | $2.1B | $1.5B | $1.4B |
| Long-term debt, less current portion | $3.7B | $3.7B | $4.3B | $4.5B |
| Operating lease obligations, less current portion | $791.0M | $784.0M | $853.3M | $970.6M |
| Finance lease obligations, less current portion | $93.7M | $109.9M | $73.8M | $88.0M |
| Long-term deferred tax liability | $15.1M | $8.3M | $103.4M | $69.8M |
| Long-term liability for uncertain tax positions | $111.4M | $103.0M | $96.0M | $95.2M |
| NCM screen advertising advances | $307.2M | $318.5M | $328.4M | $338.2M |
| Other long-term liabilities | $96.2M | $88.8M | $82.4M | $74.6M |
| Total long-term liabilities | $6.3B | $6.4B | $7.1B | $7.5B |
| Common stock value | $100.0K | $100.0K | $100.0K | $100.0K |
| Treasury stock shares | -539.8M | -103.2M | -98.3M | -95.4M |
| Additional paid-in-capital | $3.0B | $2.8B | $2.7B | $2.7B |
| Accumulated deficit | ($822.1M) | ($412.4M) | ($1.0B) | ($1.4B) |
| Accumulated other comprehensive loss | ($778.8M) | ($836.2M) | ($730.6M) | $709.5M |
| Total equity | $852.1M | $1.5B | $901.1M | $482.8M |
| Noncontrolling interests | $8.6M | $9.0M | $9.0M | $9.3M |
| Total equity | $869.3M | $1.5B | $919.1M | $501.4M |
| Total liabilities and equity | $8.9B | $10.0B | $9.5B | $9.4B |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $1.0B | $523.1M | $922.2M | $1.9B |
| Inventories | $64.6M | $65.0M | $60.0M | $66.4M |
| Accounts receivable | $225.8M | $161.0M | $164.0M | $202.0M |
| Current income tax receivable | $116.6M | $125.1M | $114.4M | $88.4M |
| Prepaid expenses and other | $104.4M | $92.8M | $95.1M | $98.2M |
| Accounts receivable from parent | $116.9M | $114.4M | $91.3M | $84.3M |
| Total current assets | $1.6B | $1.1B | $1.4B | $2.4B |
| Theater properties and equipment, net | $2.3B | $2.3B | $2.3B | $2.2B |
| Operating lease right-of-use assets, net | $1.9B | $1.9B | $1.8B | $1.9B |
| Goodwill | $1.2B | $1.2B | $1.2B | $1.2B |
| Intangible assets, net | $600.8M | $600.8M | $300.4M | $300.5M |
| Long-term deferred tax asset | $123.7M | $178.9M | $146.2M | $151.8M |
| Deferred charges and other assets | $63.4M | $65.2M | $51.2M | $48.0M |
| Total other long-term assets | $3.4B | $3.4B | $3.4B | $3.4B |
| Total assets | $9.2B | $8.8B | $8.9B | $9.9B |
| Current portion of long-term debt | $12.6M | $12.8M | $12.8M | $472.4M |
| Current portion of operating lease obligations | $430.4M | $433.2M | $431.0M | $429.8M |
| Current portion of finance lease obligations | $33.6M | $33.4M | $32.4M | $32.0M |
| Current income tax payable | $13.4M | $17.7M | $9.0M | $5.8M |
| Accounts payable and accrued expenses | $1.3B | $1.1B | $1.0B | $1.1B |
| Total current liabilities | $1.8B | $1.6B | $1.7B | $2.1B |
| Long-term debt, less current portion | $3.7B | $3.7B | $3.7B | $3.7B |
| Operating lease obligations, less current portion | $1.5B | $1.6B | $1.5B | $1.6B |
| Finance lease obligations, less current portion | $169.8M | $179.0M | $195.8M | $203.6M |
| Long-term deferred tax liability | $64.6M | $19.9M | $11.3M | $12.4M |
| Long-term liability for uncertain tax positions | $114.6M | $113.0M | $111.6M | $107.0M |
| NCM screen advertising advances | $601.8M | $608.6M | $620.2M | $625.8M |
| Other long-term liabilities | $101.1M | $95.3M | $97.6M | $93.9M |
| Total long-term liabilities | $6.3B | $6.3B | $6.3B | $6.4B |
| Common stock | $100.0K | $100.0K | $100.0K | $100.0K |
| Additional paid-in-capital | $3.0B | $3.0B | $2.9B | $2.8B |
| Treasury stock | ($585.6M) | ($560.2M) | ($464.1M) | ($322.2M) |
| Retained earnings (accumulated deficit) | ($623.5M) | ($855.5M) | ($721.0M) | ($312.7M) |
| Accumulated other comprehensive loss | ($765.0M) | ($770.2M) | ($789.4M) | ($793.8M) |
| Total Cinemark Holdings, Inc.'s stockholders' equity | $1.1B | $825.0M | $939.3M | $1.4B |
| Noncontrolling interests | $18.8M | $17.2M | $18.0M | $18.4M |
| Total equity | $1.1B | $842.2M | $957.3M | $1.5B |
| Total liabilities and equity | $9.2B | $8.8B | $8.9B | $9.9B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income | $290.0M | $312.9M | $191.5M | ($268.0M) |
| Depreciation | $402.8M | $390.8M | $414.6M | $471.4M |
| Amortization of intangible and other assets | $1.0M | $4.2M | $4.4M | $5.0M |
| Loss on debt amendments and extinguishments | $1.5M | ($6.9M) | ($10.7M) | $0 |
| Loss on warrants | $0 | — | — | — |
| Amortization of original issue discount and debt issuance costs | $12.3M | $14.6M | $16.9M | $18.4M |
| Interest accrued on NCM screen advertising advances | $0 | ($22.0M) | $0 | $0 |
| Amortization of accumulated (gains) losses for amended swap agreements | $7.2M | ($28.8M) | ($12.8M) | $9.0M |
| Impairment of long-lived and other assets | $6.5M | $1.5M | $16.6M | $174.1M |
| Share-based awards compensation expense | $36.5M | $33.5M | $25.0M | $21.5M |
| (Gain) loss on disposal of assets and other | $4.2M | $3.2M | ($15.4M) | ($13.6M) |
| Change in unrealized (gain) loss on investment in NCMI | $0 | ($21.8M) | ($24.8M) | — |
| Non-cash rent expense | ($11.2M) | ($12.5M) | ($17.9M) | $10.8M |
| Equity in loss (income) of affiliates | ($13.2M) | ($23.8M) | ($7.2M) | $18.6M |
| Deferred income tax expense (benefit) | ($19.2M) | ($110.8M) | $10.6M | ($9.3M) |
| Distributions from equity investees | $17.8M | $18.6M | $11.4M | $13.8M |
| Inventories | $3.8M | ($15.4M) | $600.0K | ($16.4M) |
| Accounts receivable | ($22.7M) | ($49.9M) | ($24.1M) | ($4.2M) |
| Income tax receivable | ($20.9M) | $3.8M | ($23.6M) | $3.0M |
| Prepaid expenses and other | ($4.2M) | ($7.5M) | ($4.6M) | ($4.6M) |
| Deferred charges and other assets, net | ($4.0M) | $3.6M | $600.0K | ($2.4M) |
| Accounts payable and accrued expenses | $6.1M | $178.2M | $91.5M | ($50.0M) |
| Income tax payable | $1.2M | ($400.0K) | $2.0M | $6.4M |
| Liabilities for uncertain tax positions | $8.4M | $7.0M | ($200.0K) | $4.0M |
| Other long-term liabilities | $200.0K | $6.8M | $2.2M | $12.4M |
| Net cash (used for) provided by operating activities | $804.2M | $938.8M | $899.1M | $289.4M |
| Additions to theatre properties and equipment and other | ($437.8M) | ($301.6M) | ($299.0M) | ($110.7M) |
| Net proceeds from sale of subsidiary | $0 | $0 | $29.6M | — |
| Proceeds from sale of theater properties and equipment and other | $19.4M | $6.6M | $5.8M | $28.8M |
| Net cash provided by investing activities | ($418.4M) | ($293.8M) | ($263.6M) | ($192.6M) |
| Distributons Paid to Parent | ($653.2M) | — | — | — |
| Dividends paid to stockholders | ($38.9M) | — | — | — |
| Repurchases of common stock under share repurchase program | ($275.1M) | — | — | — |
| Repayment of 4.50% Senior Convertible Notes | ($460.0M) | — | — | — |
| Settlements related to warrant unwind agreements | ($97.9M) | — | — | — |
| Proceeds from amendment of senior secured credit facility | $0 | $0 | $1.3B | — |
| Repayment of term loan upon amendment of senior secured credit facility | $0 | $0 | ($1.2B) | — |
| Proceeds from issuance of 7.00% Senior Notes | $0 | $1.0B | $0 | $0 |
| Payment of debt issuance costs | ($2.4M) | ($20.6M) | ($15.0M) | $0 |
| Payment of fees for debt amendments and extinguishments | ($400.0K) | ($3.2M) | — | — |
| Other repayments of long-term debt | ($12.8M) | ($25.2M) | ($21.2M) | ($56.2M) |
| Restricted stock withholdings for payroll taxes | -36.2M | -9.8M | -5.8M | -4.3M |
| Payments on finance leases | ($15.4M) | ($15.3M) | ($14.4M) | ($14.3M) |
| Other financing activities | ($800.0K) | ($6.8M) | ($1.0M) | ($11.0M) |
| Net cash used for financing activities | ($1.6B) | ($206.2M) | ($250.8M) | ($104.4M) |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net loss | $271.6M | ($10.9M) | $234.5M | $122.2M |
| Depreciation | $206.4M | $103.2M | $298.6M | $197.4M |
| Amortization of intangible and other assets | $0 | $0 | $1.0M | $400.0K |
| Loss on debt amendments and extinguishments | ($2.8M) | $3.7M | ($1.5M) | ($1.5M) |
| Amortization of original issue discount and debt issuance costs | $5.0M | $2.6M | $9.7M | $6.9M |
| Interest accrued related to significant financing component | $10.4M | $5.2M | $16.0M | $10.7M |
| Amortization of accumulated losses for amended swap agreements | $3.6M | $1.8M | $5.4M | $3.6M |
| Impairment of long-lived and other assets | $0 | — | $2.2M | $1.6M |
| Share-based awards compensation expense | ($17.6M) | ($8.7M) | ($26.1M) | ($15.8M) |
| Loss (gain) on disposal of assets and other | $13.0M | $3.7M | ($200.0K) | ($6.2M) |
| Net loss (gain) on investment in NCMI | $400.0K | $3.7M | $9.3M | $7.8M |
| Non-cash rent expense | ($5.6M) | ($2.9M) | ($8.5M) | ($5.6M) |
| Equity in income of affiliates | ($6.4M) | ($5.4M) | ($10.2M) | ($7.0M) |
| Deferred income tax expense (benefit) | $68.3M | ($31.4M) | $800.0K | ($2.7M) |
| Distributions from equity investees | $8.6M | $7.8M | $16.0M | $13.4M |
| Changes in assets and liabilities and other | $91.5M | ($128.6M) | ($145.1M) | ($37.1M) |
| Net cash used for operating activities | $679.7M | ($40.6M) | $508.4M | $321.2M |
| Additions to theater properties and equipment | ($198.6M) | ($75.4M) | ($211.2M) | ($104.4M) |
| Proceeds from sale of theater properties and equipment and other | $400.0K | $400.0K | $14.0M | $14.0M |
| Net cash used for investing activities | ($198.2M) | ($75.0M) | ($197.2M) | ($90.4M) |
| Distributions to parent (see Note 16) | ($47.5M) | ($10.5M) | ($509.1M) | — |
| Payment of debt issuance costs | ($1.2M) | — | ($2.4M) | ($1.6M) |
| Payment of fees for debt amendments and extinguishments | ($600.0K) | — | — | — |
| Repayments of long-term debt | ($6.4M) | ($3.2M) | $0 | $0 |
| Restricted stock withholdings for payroll taxes | -41.0M | -40.8M | -35.2M | -34.8M |
| Payments on finance leases | ($8.1M) | ($4.0M) | ($11.5M) | ($7.6M) |
| Other financing activities | ($3.9M) | ($900.0K) | $1.3M | $3.6M |
| Dividends paid to stockholders | ($21.0M) | ($10.5M) | ($28.3M) | ($19.1M) |
| Repurchases of common stock under share repurchase program | ($25.3M) | $0 | ($200.0M) | ($200.0M) |
| Net cash used for financing activities | ($163.1M) | ($73.9M) | ($1.3B) | ($273.9M) |
| Effect of exchange rate changes on cash and cash equivalents | $200.0K | $24.2M | $32.2M | $18.0M |
| Decrease in cash and cash equivalents | $318.6M | ($165.3M) | ($962.5M) | ($25.1M) |
| Beginning of period | $688.4M | $688.4M | $1.9B | $1.9B |
| End of period | $1.0B | $523.1M | $922.2M | $1.9B |
Cinemark Holdings Inc. score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.